The impact of cancer exceeds the amount of money devoted to it, expert says.
Cancer is the world's top "economic killer" as well as its
likely leading cause of death, the American Cancer Society contends in a
new report it will present at a global cancer conference in China this
week.
Cancer costs more in productivity and lost life than AIDS, malaria,
the flu and other diseases that spread person-to-person, the report
concludes.Chronic diseases including cancer, heart disease and diabetes account for more than 60 percent of deaths worldwide but less than 3 percent of public and private funding for global health, said Rachel Nugent of the Center for Global Development, a Washington-based policy research group.
Cancer is taking an increasing toll of people in poor countries. At
least some of those deaths are preventable at relatively low cost.
Experts say it is time to wage war on cancer in the developing world in
the same way that we fight HIV/Aids.Aids, malaria and TB hit the sympathy button, as diseases of poor countries that those of us lucky enough to live in the wealthy parts of the world think something ought to be done about. But not cancer. There's a feeling it's a rich man's sickness - that probably people in the developing world don't survive rampant infectious diseases long enough to get it and if they do, then the sheer cost of cancer care makes it impossible to help.
Death rates from breast cancer have fallen faster in the UK than any other major European country, experts have said. Research from 30 countries found large declines in the number of women dying, particularly in the UK and Iceland. Typically, death rates from breast cancer fell by almost a fifth
across the countries, ranging from a 45% reduction in Iceland to a 17%
increase in Romania.
Foto mamo.cz
opean Institute for Gender Equality Gender organizes competition
“Women Inspiring Europe” again. The most striking women each year are
invited to submit nominations for this contest. 12 successful women from
all the Europe will go to the “Women Inspiring Europe” calendar.
Clinical trials of a vaccine designed to protect healthy women against breast cancer could begin within the next two years.The jab is still under development, but its effectiveness has impressed doctors who tested it on animals prone to the disease.
If the vaccine works on human patients, researchers say GPs could offer it to women before they reach their mid-40s, when the risk of breast cancer starts to rise steeply."We think it will provide substantial protection," Vincent Tuohy, an immunologist at the Cleveland Clinic, in Ohio, US, said."Our view is that breast cancer is a completely preventable disease."
